Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether the drug BG00012 can improve the symptoms
of rheumatoid arthritis (RA) in patients who are already taking methotrexate for RA, but who
still suffer symptoms of RA. The purpose is also to ensure that the combination of
methotrexate is safe for patients to take and that any side effects are acceptable to
patients with RA.